First Time Loading...

Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 182.1 USD 0.97% Market Closed
Updated: Mar 29, 2024

Abbvie Inc
Total Assets

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
|

Abbvie Inc
Total Assets Peer Comparison

Comparables:
GILD
AMGN
VRTX
REGN
SGEN

Competitive Total Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Assets CAGR 3Y CAGR 5Y CAGR 10Y
Abbvie Inc
NYSE:ABBV
Total Assets
$134.7B
CAGR 3-Years
-4%
CAGR 5-Years
18%
CAGR 10-Years
17%
Gilead Sciences Inc
NASDAQ:GILD
Total Assets
$62.1B
CAGR 3-Years
-3%
CAGR 5-Years
0%
CAGR 10-Years
11%
Amgen Inc
NASDAQ:AMGN
Total Assets
$97.2B
CAGR 3-Years
16%
CAGR 5-Years
8%
CAGR 10-Years
4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Assets
$22.7B
CAGR 3-Years
25%
CAGR 5-Years
29%
CAGR 10-Years
26%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Assets
$33.1B
CAGR 3-Years
24%
CAGR 5-Years
23%
CAGR 10-Years
27%
Seagen Inc
NASDAQ:SGEN
Total Assets
$3.6B
CAGR 3-Years
7%
CAGR 5-Years
18%
CAGR 10-Years
22%

See Also

What is Abbvie Inc's Total Assets?
Total Assets
134.7B USD

Based on the financial report for Dec 31, 2023, Abbvie Inc's Total Assets amounts to 134.7B USD.

What is Abbvie Inc's Total Assets growth rate?
Total Assets CAGR 10Y
17%

Over the last year, the Total Assets growth was -3%. The average annual Total Assets growth rates for Abbvie Inc have been -4% over the past three years , 18% over the past five years , and 17% over the past ten years .